#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4219513	B	Proteolysis targeting chimera activity in human HeLa cells assessed as induction of VCB-mediated delivery of BRD4 short isoform for protein degradation by proteasome by measuring drug level causing 50% cellular protein depletion incubated for 24 hrs by Western blotting method	Homo sapiens	7	ALA4219029	cell-based format	Scientific Literature
2.	ALA4219514	B	Proteolysis targeting chimera activity in human HeLa cells assessed as induction of VCB-mediated delivery of BRD4 long isoform for protein degradation by proteasome by measuring drug level causing 50% cellular protein depletion incubated for 24 hrs by Western blotting method	Homo sapiens	7	ALA4219029	cell-based format	Scientific Literature
3.	ALA4219515	B	Proteolysis targeting chimera activity in human HeLa cells assessed as induction of VCB-mediated delivery of BRD3 for protein degradation by proteasome by measuring drug level causing 50% cellular protein depletion incubated for 24 hrs by Western blotting method	Homo sapiens	7	ALA4219029	cell-based format	Scientific Literature
4.	ALA4219516	B	Proteolysis targeting chimera activity in human HeLa cells assessed as induction of VCB-mediated delivery of BRD2 for protein degradation by proteasome by measuring drug level causing 50% cellular protein depletion incubated for 24 hrs by Western blotting method	Homo sapiens	5	ALA4219029	cell-based format	Scientific Literature
5.	ALA4219517	B	Proteolysis targeting chimera activity in human MV4-11 cells assessed as induction of VCB-mediated delivery of BRD4 for protein degradation by proteasome by measuring cellular protein depletion at 50 nM incubated for 4 hrs by Western blotting method	Homo sapiens	9	ALA4219029	cell-based format	Scientific Literature
6.	ALA4219518	F	Antiproliferative activity against human HL60 cells after 48 hrs by CellTiter-Glo luminescent cell viability assay	Homo sapiens	9	ALA4219029	cell-based format	Scientific Literature
7.	ALA4219519	B	Proteolysis targeting chimera activity in human HeLa cells assessed as induction of VCB-mediated delivery of BRD4 short isoform for protein degradation by proteasome by measuring drug level causing 50% cellular protein depletion incubated for 24 hrs by Western blotting method relative to control	Homo sapiens	7	ALA4219029	cell-based format	Scientific Literature
8.	ALA4219520	B	Proteolysis targeting chimera activity in human HeLa cells assessed as induction of VCB-mediated delivery of BRD4 long isoform for protein degradation by proteasome by measuring drug level causing 50% cellular protein depletion incubated for 24 hrs by Western blotting method relative to control	Homo sapiens	7	ALA4219029	cell-based format	Scientific Literature
9.	ALA4219521	B	Proteolysis targeting chimera activity in human HeLa cells assessed as induction of VCB-mediated delivery of BRD3 for protein degradation by proteasome by measuring drug level causing 50% cellular protein depletion incubated for 24 hrs by Western blotting method relative to control	Homo sapiens	7	ALA4219029	cell-based format	Scientific Literature
10.	ALA4219522	B	Proteolysis targeting chimera activity in human HeLa cells assessed as induction of VCB-mediated delivery of BRD2 for protein degradation by proteasome by measuring drug level causing 50% cellular protein depletion incubated for 24 hrs by Western blotting method relative to control	Homo sapiens	7	ALA4219029	cell-based format	Scientific Literature
11.	ALA4219523	F	Antiproliferative activity against human MV4-11 cells after 48 hrs by CellTiter-Glo luminescent cell viability assay	Homo sapiens	9	ALA4219029	cell-based format	Scientific Literature
12.	ALA4219524	B	Proteolysis targeting chimera activity in human MV4-11 cells assessed as induction of VCB-mediated delivery of BRD4 for protein degradation by proteasome by measuring cellular cMyc protein depletion at 50 nM incubated for 4 hrs by Western blotting method	Homo sapiens	9	ALA4219029	cell-based format	Scientific Literature
13.	ALA4219525	B	Proteolysis targeting chimera activity in human HL60 cells assessed as induction of VCB-mediated delivery of BRD4 for protein degradation by proteasome by measuring cellular protein depletion at 50 nM incubated for 4 hrs by Western blotting method	Homo sapiens	9	ALA4219029	cell-based format	Scientific Literature
14.	ALA4219526	B	Proteolysis targeting chimera activity in human HL60 cells assessed as induction of VCB-mediated delivery of BRD4 for protein degradation by proteasome by measuring cellular cMyc protein depletion at 50 nM incubated for 4 hrs by Western blotting method	Homo sapiens	9	ALA4219029	cell-based format	Scientific Literature
15.	ALA4219527	B	Binding affinity to N-terminal His6-tagged recombinant human Brd4 BD2 expressed in Escherichia coli BL21 (DE3) assessed as compound binary complex formation by isothermal titration calorimetry-based assay	Homo sapiens	6	ALA4219029	assay format	Scientific Literature
16.	ALA4219528	B	Binding affinity to N-terminal His6-tagged recombinant human VHL (54 to 213 residues)/elongin C (17 to 112 residues)/elongin B (1 to 104 residues) expressed in Escherichia coli BL21 (DE3) assessed as compound binary complex formation by isothermal titration calorimetry-based assay	Homo sapiens	6	ALA4219029	assay format	Scientific Literature
17.	ALA4219529	B	Induction of interaction of N-terminal His6-tagged recombinant human VHL (54 to 213 residues)/elongin C (17 to 112 residues)/elongin B (1 to 104 residues) co-expressed in Escherichia coli BL21 (DE3) with recombinant human Brd4 BD2 assessed as VCB/BRD4/compound ternary complex formation by isothermal titration calorimetry-based assay	Homo sapiens	6	ALA4219029	assay format	Scientific Literature